Holen Sie sich die Stockscreener-App
0.6665
3.07%
-0.0211
Sunshine Biopharma Inc Aktie (SBFM) Neueste Nachrichten
Shares traded below Nasdaq’s $1 minimum. Sunshine Biopharma (SBFM) has approved a possible reverse split. - Stock Titan
Sunshine Biopharma, Inc. (SBFM) Upgraded to Buy: Here's What You Should Know - Eastern Progress
Sunshine Biopharma, Inc. (SBFM) Stock Price, News, Quote & History - Yahoo! Finance Canada
SBFM Looks 59.3% Undervalued on GF Value™ Despite Distressed Fun - GuruFocus
Sunshine Biopharma launches generic ondansetron in Canada - Investing.com
Sunshine Biopharma launches generic ondansetron in Canada By Investing.com - Investing.com Nigeria
Sunshine Biopharma Launches Generic Zofran(R) in Canada, Expanding Oncology Supportive Care Portfolio - Corsicana Daily Sun
A generic drug for nausea during cancer treatment launches in Canada - Stock Titan
Sunshine Biopharma Inc (SBFM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Sunshine Biopharma Stock (SUNB) Opinions on Coronavirus Drug Studies - Quiver Quantitative
Sunshine Biopharma Authorizes Reverse Stock Split of Up to 1-for-20 - Minichart
Sunshine Biopharma CEO Authorizes Potential Reverse Stock Split - TipRanks
SBFM Looks 51.6% Undervalued on GF Value™ Despite Distressed Fun - GuruFocus
Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies - Weatherford Democrat
An oral drug candidate suppressed lung virus in infected mice - Stock Titan
EXCLUSIVE: Sunshine Biopharma Advances 'Differentiated Antiviral Candidate' to IND-Enabling Studies - Yahoo Finance
Sunshine Biopharma Adjusts Series B Warrant Exercise Price - TipRanks
Form 8K Sunshine Biopharma Inc For: 11 September By Investing.com - Investing.com South Africa
Sunshine Biopharma reduces Series B warrant exercise price to $1.2046 By Investing.com - Investing.com South Africa
Sunshine Biopharma reduces Series B warrant exercise price to $1.2046 - Investing.com
Sunshine Biopharma (NASDAQ: SBFM) Anticipates $31M from Series B Warrant Exercises - kalkinemedia.com
Price to earnings forward of Sunshine Biopharma Inc. – BOATS:SBFMW - TradingView
Price to sales forward of Sunshine Biopharma Inc. – BOATS:SBFMW - TradingView
Sunshine Biopharma Inc. SEC Filing (Sep 9, 2026) - Stock Titan
Sunshine Biopharma Inc. (SBFM) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Sunshine Biopharma Inc. (SBFM) Peer Comparison – Compare with Others - Value Research
Sunshine Biopharma receives Canadian approval for atenolol tablets By Investing.com - Investing.com Nigeria
Sunshine Biopharma Announces Board Vacancy as Dr. Andrew Keller Steps Down After Term Ends - kalkinemedia.com
SBFM Looks 52.9% Undervalued on GF Value™ Despite Weak Fundamentals - GuruFocus
Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions - Cadillac News
Health Canada approves Atenolol, a drug used for high blood pressure and chest pain - Stock Titan
Sunshine Biopharma Inc. Warrant (SBFMW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Sunshine Biopharma (NASDAQ: SBFM) could raise $31M from warrants - Stock Titan
Dr. Andrew Keller to Leave Sunshine Biopharma Board at Term End - TradingView
Sunshine Biopharma Inc. Announces Term Completion of Dr. Andrew Keller as Director - marketscreener.com
Sunshine Biopharma Reports In Vivo Tumor Suppression with K1.1 mRNA and Advances Novel mRNA-Cancer Vaccine Strategy for Lung Cancer - The Batesville Daily Guard
Sunshine Biopharma Inc. Warrant (SBFMW) Key Financial Ratios – Valuation, Profitability & More - Value Research
Sunshine (SBFMW) Market: Closes Nearly Flat at $0.05 in the Available Record; Levels: the Current Price Sits Inside the Supplied Technical RangeExhaustion Gap - vinanet.vn
Sunshine Biopharma wins Canadian approval for generic Enalapril tablets - Bitget
SBFM Looks 55.2% Undervalued on GF Value™ Despite Challenging Fu - GuruFocus
BRIEF-Sunshine Biopharma Receives Canadian Regulatory Approval For Enalapril - Bitget
Sunshine Biopharma receives Canadian approval for generic enalapril By Investing.com - Investing.com Canada
Sunshine Biopharma receives Canadian approval for generic enalapril - Investing.com
Sunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug Market - Eagle-Tribune
EXCLUSIVE: Sunshine Biopharma Secures Canadian Approval for Generic Hypertension Drug - Yahoo Finance
Sunshine (SBFM) Quarterly Performance Check: The Company Lists Its Latest Available Figures in the Reported Period; Session Reaction: The Stock Ends Up 1.79% in the Latest ReadingEarnings Momentum Score - vinanet.vn
101,973 Common Stock of Sunshine Biopharma, Inc. are subject to a Lock-Up Agreement Ending on 18-AUG-2026. - marketscreener.com
Sunshine Biopharma earnings beat by $0.05, revenue topped estimates - Investing.com
1.15%
5.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):